PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 6 days 22 hours 11 minutes
Improving Outcomes in Early-Stage EGFR-Mutant NSCLC: What Pathologists Can Do
"Improving Outcomes in Early-Stage EGFR-Mutant NSCLC: What Pathologists Can Do"
Evaluating the Role of Oral Hypomethylating Agents in MDS: Considerations to Optimize Care
Evaluating the Role of Oral Hypomethylating Agents in MDS: Considerations to Optimize Care
From Bench to Bedside: Evaluating the Role of Maintenance Therapy to Improve Outcomes in Patients With AML
From Bench to Bedside: Evaluating the Role of Maintenance Therapy to Improve Outcomes in Patients With AML
Optimizing Care for Unresectable Malignant Pleural Mesothelioma: Challenges and Solutions
Optimizing Care for Unresectable Malignant Pleural Mesothelioma: Challenges and Solutions
Strategies to Maximize Long-Term Outcomes in Patients With Chronic Lymphocytic Leukemia (CLL)
Strategies to Maximize Long-Term Outcomes in Patients With Chronic Lymphocytic Leukemia (CLL)
Asked and Answered: Differentiating Between PARP Inhibitors in First-Line Advanced Ovarian Cancer
Asked and Answered: Differentiating Between PARP Inhibitors in First-Line Advanced Ovarian Cancer
Cases in Patient-Centred Care of ITP: Expert Guidance to Optimize Diagnosis and Treatment
Cases in Patient-Centred Care of ITP: Expert Guidance to Optimize Diagnosis and Treatment
Evolving Treatment Paradigm in Early-Stage EGFR-Mutant NSCLC: A Primer for Medical Oncologists
Evolving Treatment Paradigm in Early-Stage EGFR-Mutant NSCLC: A Primer for Medical Oncologists
Best Practices in Early-Stage EGFR-Mutant NSCLC: A Primer for Radiation Oncologists
Best Practices in Early-Stage EGFR-Mutant NSCLC: A Primer for Radiation Oncologists
Improving Outcomes in Localised EGFR-Mutant NSCLC: Perspectives for Pulmonologists
Improving Outcomes in Localised EGFR-Mutant NSCLC: Perspectives for Pulmonologists